Stoked Bio is at the forefront of redefining drug discovery by combining the latest advances in artificial intelligence with deep-rooted expertise in biology. Our platform, which uses cutting-edge neural-based approaches, allows for the quick and cost-effective discovery of structurally innovative pharmaceuticals across a wide range of therapeutic domains. We use molecular property prediction algorithms and de novo molecular design algorithms capable of exploring large chemical spaces to target crucial areas of need. These include antibiotic resistance, cancer, fungal infections, and other infectious diseases.

Our objective is clear: use AI methods to improve the number of novel chemical entities found while greatly reducing the time and expense of developing new drugs. We are a self-sustaining, world-class Canadian drug research and development organization building collaborations with early-stage biotech businesses and concentrating on revenue-generating partnerships. Our mission is to revolutionize the pharmaceutical industry, driving innovation and meeting urgent medical needs via a portfolio of ground-breaking therapies. Stoked Bio is dedicated to promoting drug development, guaranteeing fair access to life-saving therapies, and having a significant influence on global public health.

We are people who happen to be scientists who happen to strive to discover new medicines that treat infectious diseases and cancers with few or no treatment options. We happen to think that AI is a powerful set of approaches to achieve this goal. We happen to love each other, our work, and the patients who will benefit from our discoveries. Lots of companies suck, we don’t.